Algernon Pharmaceuticals Inc. (CSE:AGN)
0.0700
0.00 (0.00%)
Aug 8, 2025, 3:59 PM EDT
Algernon Pharmaceuticals Market Cap
Algernon Pharmaceuticals has a market cap or net worth of CAD 2.49 million as of August 8, 2025. Its market cap has decreased by -5.33% in one year.
Market Cap
2.49M
Enterprise Value
2.40M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since February 1, 2016, Algernon Pharmaceuticals's market cap has decreased from 17.71M to 2.49M, a decrease of -85.96%. That is a compound annual growth rate of -18.63%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 2.49M | 30.12% |
Dec 31, 2024 | 1.91M | 50.70% |
Dec 29, 2023 | 1.27M | -75.16% |
Dec 30, 2022 | 5.10M | -25.66% |
Dec 31, 2021 | 6.87M | -78.12% |
Dec 31, 2020 | 31.38M | 695.28% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Feb 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Green Thumb Industries | 2.28B |
Curaleaf Holdings | 2.14B |
Sienna Senior Living | 1.72B |
dentalcorp Holdings | 1.62B |
Trulieve Cannabis | 1.51B |
Cronos Group | 1.23B |
WELL Health Technologies | 1.22B |
Extendicare | 1.10B |